SNAMI. Now also the state drug!

Angelo Testa: “Ennesima follia che calpesta lo stato di diritto a potersi curare. Di fatto un ricatto a Medici e pazienti ad utilizzare un “ farmaco similare ” che potrebbe avere un principio attivo differente”

SNAMI – Comunicato 24 maggio 2016

MEDICINAL PRODUCTS WITH THERAPEUTIC EQUIVALENCE

Roma 24 Maggio 2016-Commento del sindacato autonomo ai tagli su un gran numero di farmaci che diventerebbero a pagamento per i malati, “A meno che” dice Angelo Testa, presidente nazionale dello Snami “i pazienti non vogliano cambiare terapia con un “farmaco similare”. Il tutto, ovviamente,per una questione di tagli immediati, il percorso tutto Italiano del “mordi e fuggi “del risparmio dell’oggi, che non tiene conto dei costi del domani, soprattutto in termini di salute pubblica.

There is an AIFA "determination", the "458" of last March 31 on the theme "Therapeutic equivalence between medicines containing different active ingredients", which makes us understand where we want to end up. The hypertensive patient who for years has been able to control his blood pressure with a given drug will henceforth have to pay for it or else he will have to accept, because he cannot afford it, the "state" drug which perhaps has a different active principle, with the aggravating factor that the following year the same could happen, therefore having to change again and consequently "having to discard" the medicine taken to replace thereceding. Again not with the same active ingredient.

Follia totale” denuncia il leader dello Snami “da aggiungere alla telenovela del decreto taglia esami e ad un insieme di idiozie che vorrebbero impedire ai Medici di svolgere la loro professione e ai cittadini di potersi curare”

Snami Press Office

Related news: Indecent Italy: between unjustified millionaire prizes and cuts in drug spending. Press release Fedaiisf

Therapeutic equivalence, Garattini: Aifa is going in the right direction. Possible revolution

Fimmg on procurement tenders for drugs with 'therapeutic equivalence'

Determines AIFA 458/2016

Scaccabarozzi (Farmindustria) on the proposal of the governors: «From the Regions only an old expired recipe» Thrust against therapeutic equivalence

Healthcare, the reimbursement of 1,500 drugs at risk. "Sick people will have to pay or be treated with different active ingredients"

Pharmaceutical governance. Yes to price/volume and innovation. Doubts about double territorial ceiling and competition measures. The proposals of the Regions scrutinized by the Table of Palazzo Chigi

Avastin-Lucentis case: they take away our essential drugs but leave us with Lucentis

NHS crisis, the recipe can no longer be private healthcare